Dr. David C. U'Prichard joined 3-Dimensional Pharmaceuticals, Inc. in September 1999 as our CEO and a member of our Board of Directors. From 1997 to 1999, Dr. U'Prichard served as President of Research and Development at SmithKline Beecham. While at SmithKline Beecham, Dr. U'Prichard oversaw the entry of approximately ten compounds into global development, the international registration of the diabetes drug Avandia® * and the entry of four compounds into Phase III trials and six compounds into early clinical trials; additionally, he instituted several major restructuring efforts at the company. Prior to SmithKline Beecham, he worked for ICI/Zeneca from 1986 to 1997, as Executive Vice President and International Research Director from 1994 to 1997. Previously, Dr. U'Prichard was instrumental in the launch of Nova Pharmaceuticals in 1983, following an academic career as the Associate Professor of Pharmacology and Neurobiology at Northwestern University Medical School (1978-83), and his postdoctoral fellowship at Johns Hopkins University (1975-78). Dr. U'Prichard received his Ph.D. in Pharmacology from the University of Kansas, and his B.S. in Pharmacology with first-class honors from the University of Glasgow, Scotland. He has held academic appointments at Northwestern University, Johns Hopkins University and the University of Pennsylvania and is an Honorary Professor at the University of Glasgow. He is also an author of more than 100 primary and review publications, was a founding co-editor of Molecular Neurobiology and co-editor of Epinephrine in the Central Nervous System and has served as a member of various editorial boards. Dr. U'Prichard serves on the Board of Directors of Lynx Therapeutics, Inc., Predict, Inc, RiboTargets PLC (1999-2002), and GeneMatrix, and is on the Board of the Pennsylvania Biotechnology Association.
Dr. U'Prichard and his wife Lisa are active philanthropists with strong interests in pursuing sustainable development goals, especially in Mexico and India. They started the Sam and Charles Foundation 5 years ago to provide financial support to sustainable development initiatives, including several at the Centro Ecologico de Akumal (CEA) in Quintana Roo, Mexico.
Back |
